Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Long-Term Investments (2019 - 2025)

Historic Long-Term Investments for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to $1.0 million.

  • Pharming's Long-Term Investments fell 108.27% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 108.27%. This contributed to the annual value of $466000.0 for FY2024, which is 7960.61% down from last year.
  • As of Q3 2025, Pharming's Long-Term Investments stood at $1.0 million, which was down 108.27% from $1.0 million recorded in Q2 2025.
  • Pharming's 5-year Long-Term Investments high stood at $7.6 million for Q2 2022, and its period low was $2845.0 during Q3 2022.
  • Moreover, its 5-year median value for Long-Term Investments was $1.5 million (2023), whereas its average is $2.3 million.
  • Its Long-Term Investments has fluctuated over the past 5 years, first soared by 9854583.33% in 2022, then plummeted by 7960.61% in 2024.
  • Quarter analysis of 5 years shows Pharming's Long-Term Investments stood at $7.3 million in 2021, then crashed by 65.56% to $2.5 million in 2022, then dropped by 8.64% to $2.3 million in 2023, then tumbled by 79.61% to $466000.0 in 2024, then soared by 115.67% to $1.0 million in 2025.
  • Its Long-Term Investments was $1.0 million in Q3 2025, compared to $1.0 million in Q2 2025 and $672000.0 in Q1 2025.